Browse studies

Find your next paid study

168 recruiting studies matching your filters

A Phase 2a, Multi-Center, Placebo-Controlled, Double-Blinded, Randomized, Dose Ranging Study of the Preliminary Efficacy of DARE-HPV to Treat Persistent High-Risk Human Papillomavirus (HPV) Genital Infection

The goal of this clinical study is to learn if DARE-HPV can treat persistent high-risk human papillomavirus (hrHPV). The primary outcome will be if the genital…

Human Papilloma Virus (HPV)High-risk Human Papillomavirus Infection

Estimated

~$10 – $8,750

Daré Bioscience, Inc.NCT07601074

Phase 2

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Background: Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS) and KSHV-multicentric Castleman disease (MCD) occur in people l…

KSHV Inflammatory Cytokine Syndrome (KICS)Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06052618

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of childre…

Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22 more

Estimated

~$10 – $750

Duke UniversityNCT04278404

Immune Registry for BK (Polyomavirus Hominis 1) in Kidney Transplant Recipients

Kidney transplantation (KT) is the best treatment modality available to date for patients with advanced kidney disease and the success of KT is dependent on ma…

BK Virus InfectionKidney Transplant; Complications

Estimated

~$10 – $750

Virginia Commonwealth UniversityNCT06538961

Phase 1

Phase I Dose Escalation Study of the Use of ACU-D1, a Topical Proteasome Inhibitor in HPV Associated Vulvar and Perianal Lesions in People With HIV

The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main questio…

Human Papilloma VirusHuman Immunodeficiency VirusAnal Intraepithelial Neoplasia+1 more

Estimated

~$10 – $6,250

Emory UniversityNCT06233331

Rapid HIV, Hepatitis C, and Syphilis Screening in a Rural Street Medicine Clinic in West Virginia

West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health ch…

HIV TestingHEPATITIS C (HCV)Syphilis+1 more

Estimated

~$10 – $750

West Virginia UniversityNCT07317687

Observational

Developing and Implementing HPV SCREENED (Self-Collection REach and ENgagement in Emergency Departments) to Improve Cancer Equity

This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emerge…

Cervical Cancer ScreeningHuman Papilloma Virus

Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT07657104

Observational

Uptake of HPV Self-sampling in Underserved Minority Women Using a Community Health Worker Model: Comparison of Evalyn Brush and Copan Floqswab

Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibil…

Cervical CancerHpvHuman Papilloma Virus+1 more

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07336134

Phase 2

Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

The goal of this clinical trial is to compare antiviral treatment strategies for cytomegalovirus (CMV) anterior uveitis - a viral infection causing inflammatio…

Cytomegalovirus (CMV)Anterior UveitisInfectious Uveitis+1 more

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07513623

Observational

MIA-COMP Pivotal Study: COMParative Self-Collection for Cervical Cancer Screening

To evaluate whether individuals drawn from the intended use population can successfully interpret and follow the IFU for the Mia by XytoTest self-collection de…

HPVHPV - Anogenital Human Papilloma Virus Infection

Estimated

~$10 – $7,500

Mel Mont MedicalNCT07758140

Phase 1

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent and in co…

Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more

Estimated

~$10 – $8,750

Marengo Therapeutics, Inc.NCT05592626

Phase 2

Psilocybin Recovery Intervention for Stopping Methamphetamine Use

The goal of this clinical trial is to learn whether it is possible to use psilocybin in combination with motivational support therapy to treat moderate-to-seve…

Methamphetamine Use DisorderHuman Immunodeficiency Virus (HIV)

Estimated

~$10 – $7,500

Nicky Mehtani, MD, MPHNCT07756736